Intensive Weight Loss Intervention Versus Usual Care for Adults With Obesity
- Disease/Condition
- Obesity
- Drug/Device/Intervention
- Intensive weight loss intervention
- Study type
- Interventional
- Intervention type
- behavioral
- Primary sponsor
- Carsten Dirksen
- Funder
- Copenhagen University Hospital, Hvidovre
- Location
- Copenhagen,Frederiksberg,Frederiksberg,Hvidovre,Søborg,Oxford, Denmark,United Kingdom
- Phase
- N/A
- Start date
- May 01, 2024
- End date
- Dec 01, 2048
- Enrollment
- 400 participants
Weight
In this trial, the aim is to assess the clinical benefits and harms, as well as
 cost-effectiveness of an intensive weight loss (IWL) intervention that includes total dietary
 replacements, behavioural support and weight-loss medication compared with existing weight
 management programmes within primary care for people with obesity class I or uncomplicated
 obesity class II or higher.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06321432
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06321432 through Pure Global AI's free database. This phase not specified trial is sponsored by Carsten Dirksen and is currently Not yet recruiting. The study focuses on Obesity. Target enrollment is 400 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.